Status: Recruiting
R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia
A multicenter prospective phase II study of rituximab combined, lenalidomide, dexamethasone followed by lenalidomide maintenance in patients with newly diagnosed Waldenström's macroglobulinemia (Ballondor trial)
Participants needed: 54
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: Kosin University Gospel HospitalUpdated: Oct 6, 2023Locations: 1
Eligibility criteria
Clinicopathological diagnosis of Waldenstrom's Macroglobulinemia [+8]
Central nervous system involvement central nervous system (CNS) involvement by W... [+16]